Sort
326,823 grants matching “clinical trial”
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$1,940,003Nelson Lee Michael · Walter Reed Army Institute Of Research · UM1 · FY2016 · AI
Rapid Multipathogen Detection for POCT and National Diaster Readiness
$1,939,935Gerald Joseph Kost · University Of California At Davis · U54 · FY2008 · EB
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
$1,939,848Joseph J Cullen · University Of Iowa · P01 · FY2018 · CA
Towards Eradication: Reducing Proviral HIV DNA with Interferon-α Immunotherapy
$1,939,835Luis J. Montaner · Wistar Institute · U01 · FY2015 · AI
Mechanisms and Markers of Prostate Cancer Metastases
$1,939,670Robert Vessella · University Of Washington · P01 · FY2013 · CA
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC
$1,939,477Sandra E Juul · University Of Washington · U01 · FY2015 · NS
Hyperandrogenemia, Diet and Female Reproductive Health
$1,939,432Richard L Stouffer · Oregon Health & Science University · P50 · FY2016 · HD
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
$1,939,405Victor John Thannickal · University Of Alabama At Birmingham · P01 · FY2019 · HL
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,939,404Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2013 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,939,404Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease
$1,939,380Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
RP1: Combating Racial Health Disparities in PC: Building Mechanism-Driven Rationale for Single and Combinatorial Therapies Against Overactive Kinase Signaling and DDR using AA PDXs
$1,939,255Nicholas Mitsiades · Baylor College Of Medicine · U54 · FY2018 · CA
Rush Center for Urban Health Equity
$1,939,203Lynda H Powell · Rush University Medical Center · P50 · FY2014 · HL
Immunologic &Virologic Features of Early HIV Infection
$1,939,095University Of California San Francisco · U01 · FY2004 · AI
Centers for AIDS Research (CFAR)
$1,938,987Kent J. Weinhold · Duke University · P30 · FY2016 · AI
New York Columbia Collaborative SPOTRIAS
$1,938,841Randolph S Marshall · Columbia University Health Sciences · P50 · FY2008 · NS
Adult Brain Tumor Consortium (ABTC)
$1,938,692Stuart A Grossman · Johns Hopkins University · UM1 · FY2019 · CA
Biology and Therapy of High Risk Neuroblastoma
$1,938,669Children'S Hospital Los Angeles · P01 · FY2005 · CA
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine
$1,938,372Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Informative Clinical Studies in Asthma
$1,938,074Elliot Israel · Brigham And Women'S Hospital · U10 · FY2007 · HL
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$1,938,066Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
$1,938,064James R Cerhan · Mayo Clinic Rochester · U01 · FY2022 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
$1,938,063James R Cerhan · Mayo Clinic Rochester · U01 · FY2023 · CA
Carle Cancer Center NCI Community Oncology Research Program (NCORP)
$1,938,046Kendrith Martin Rowland · Carle Foundation · UG1 · FY2022 · CA
TOPIC 425 - AUTOMATED MOTION EXTRACTION AND ANALYSIS TO QUANTIFY PATIENT PERFORMANCE STATUS
$1,937,947Luciano Nocera · Cansera, Inc. · N43 · FY2022 · CA